1. Dubey JP. The history of
Toxoplasma gondii—the first 100 years. J Eukaryot Microbiol 2008;55:467-475.
2. Dubey JP, Rajendran C, Ferreira LR, Martins J, Kwok OC, Hill DE, Villena I, Zhou H, Su C, Jones JL. High prevalence and genotypes of
Toxoplasma gondii isolated from goats, from a retail meat store, destined for human consumption in the USA. Int J Parasitol 2011;41:827-833.
3. Nissapatorn V, Lee C, Quek KF, Leong CL, Mahmud R, Abdullah KA. Toxoplasmosis in HIV/AIDS patients: a current situation. Jpn J Infect Dis 2004;57:160-165.
4. Thomas F, Lafferty KD, Brodeur J, Elguero E, Gauthier-Clerc M, Missé D. Incidence of adult brain cancers is higher in countries where the protozoan parasite
Toxoplasma gondii is common. Biol Lett 2012;8:101-103.
5. Lebech M, Andersen O, Christensen NC, Hertel J, Nielsen HE, Peitersen B, Rechnitzer C, Larsen SO, Nørgaard-Pedersen B, Petersen E. Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment. Lancet 1999;353:1834-1837.
6. Dubey JP, Hill DE, Jones JL, Hightower AW, Kirkland E, Roberts JM, Marcet PL, Lehmann T, Vianna MC, Miska K, Sreekumar C, Kwok OC, Shen SK, Gamble HR. Prevalence of viable
Toxoplasma gondii in beef, chicken, and pork from retail meat stores in the United States: risk assessment to consumers. J Parasitol 2005;91:1082-1093.
7. Fajardo HV, D’ávila S, Bastos RR, Cyrino CD, de Lima Detoni M, Garcia JL, das Neves LB, Nicolau JL, Amendoeira MR. Seroprevalence and risk factors of toxoplasmosis in cattle from extensive and semi-intensive rearing systems at Zona da Mata, Minas Gerais state, Southern Brazil. Parasit Vectors 2013;6:191.
8. Dubey JP. Toxoplasmosis in pigs—the last 20 years. Vet Parasitol 2009;164:89-103.
9. Abugri DA, Witola WH, Jaynes JM. In vitro antagonistic and indifferent activity of combination of 3-deoxyanthocyanidins against
Toxoplasma gondii
. Parasitol Res 2017;116:3387-3400.
10. Zhu WN, Wang JL, Chen K, Yue DM, Zhang XX, Huang SY, Zhu XQ. Evaluation of protective immunity induced by DNA vaccination with genes encoding
Toxoplasma gondii GRA17 and GRA23 against acute toxoplasmosis in mice. Exp Parasitol 2017;179:20-27.
11. Buxton D, Innes EA. A commercial vaccine for ovine toxoplasmosis. Parasitology 1995;110(suppl):11-16.
12. Cao A, Liu Y, Wang J, Li X, Wang S, Zhao Q, Cong H, He S, Zhou H.
Toxoplasma gondii: vaccination with a DNA vaccine encoding T-and B-cell epitopes of SAG1, GRA2, GRA7 and ROP16 elicits protection against acute toxoplasmosis in mice. Vaccine 2015;33:6757-6762.
13. Beláková J, Horynová M, Krupka M, Weigl E, Raska M. DNA vaccines: are they still just a powerful tool for the future? Arch Immunol Ther Exp (Warsz) 2007;55:387-398.
14. Henriquez FL, Woods S, Cong H, McLeod R, Roberts CW. Immunogenetics of
Toxoplasma gondii informs vaccine design. Trends in Parasitol 2010;26:550-555.
15. Hiszczyńska-Sawicka E, Holec-Gasior L, Kur J. DNA vaccines and recombinant antigens in prevention of
Toxoplasma gondii infections--current status of the studies. Wiad Parazytol 2009;55:125-139 (in Polish).
16. Mendes ÉA, Fonseca FG, Casério BM, Colina JP, Gazzinelli RT, Caetano BC. Recombinant vaccines against
T. gondii: comparison between homologous and heterologous vaccination protocols using two viral vectors expressing SAG1. PLoS One 2013;8:e63201.
17. Cong H, Zhang M, Xin Q, Wang Z, Li Y, Zhao Q, Zhou H, He S. Compound DNA vaccine encoding SAG1/SAG3 with A2/B subunit of cholera toxin as a genetic adjuvant protects BALB/c mice against
Toxoplasma gondii
. Parasit Vectors 2013;6:63.
18. Zhou J, Wang L. SAG4 DNA and peptide vaccination provides partial protection against
T. gondii infection in BALB/c mice. Front Microbiol 2017;8:1733.
19. Hiszczyńska-Sawicka E, Olędzka G, Holec-Gąsior L, Li H, Xu JB, Sedcole R, Kur J, Bickerstaffe R, Stankiewicz M. Evaluation of immune responses in sheep induced by DNA immunization with genes encoding GRA1, GRA4, GRA6 and GRA7 antigens of
Toxoplasma gondii
. Vet Parasitol 2011;177:281-289.
20. Ahmadpour E, Sarvi S, Hashemi Soteh MB, Sharif M, Rahimi MT, Valadan R, Tehrani M, Khalilian A, Montazeri M, Daryani A. Evaluation of the immune response in BALB/c mice induced by a novel DNA vaccine expressing GRA14 against
Toxoplasma gondii
. Parasite Immunol 2017;39:e12419.
21. Yuan ZG, Ren D, Zhou DH, Zhang XX, Petersen E, Li XZ, Zhou Y, Yang GL, Zhu XQ. Evaluation of protective effect of pVAX-TgMIC13 plasmid against acute and chronic
Toxoplasma gondii infection in a murine model. Vaccine 2013;31:3135-3139.
22. Liu Q, Wang F, Wang G, Zhao Q, Min J, Wang S, Cong H, Li Y, He S, Zhou H.
Toxoplasma gondii: immune response and protective efficacy induced by ROP16/GRA7 multicomponent DNA vaccine with a genetic adjuvant B7-2. Hum Vaccin Immunother 2014;10:184-191.
23. Wang HL, Wang YJ, Pei YJ, Bai JZ, Yin LT, Guo R, Yin GR. DNA vaccination with a gene encoding
Toxoplasma gondii rhoptry protein 17 induces partial protective immunity against lethal challenge in mice. Parasite 2016;23:4.
24. Nabi H, Rashid I, Ahmad N, Durrani A, Akbar H, Islam S, Bajwa AA, Shehzad W, Ashraf K, Imran N. Induction of specific humoral immune response in mice immunized with ROP18 nanospheres from
Toxoplasma gondii
. Parasitol Res 2017;116:359-370.
25. Hu LY, Zhang NZ, Zhang FK, Wang M, Gao Q, Wang JL, Zhu XQ. Resistance to Chronic
Toxoplasma gondii infection induced by a DNA vaccine expressing GRA16. Biomed Res Int 2017;2017:1295038.
26. Quan JH, Chu JQ, Ismail HA, Zhou W, Jo EK, Cha GH, Lee YH. Induction of protective immune responses by a multiantigenic DNA vaccine encoding GRA7 and ROP1 of
Toxoplasma gondii
. Clin Vaccine Immunol 2012;19:666-674.
27. Babaie J, Zare M, Sadeghiani G, Lorgard-Dezfuli M, Aghighi Z, Golkar M. Bacterial production of dense granule antigen GRA8 of
Toxoplasma gondii
. Iran Biomed J 2009;13:145-151.
28. Babaie J, Miri M, Sadeghiani G, Zare M, Khalili G, Golkar M. Expression and Single-step Purification of GRA8 Antigen of
Toxoplasma gondii in Escherichia coli. Avicenna J Med Biotechnol 2011;3:67-77.
29. Costa JG, Duré AB. Immunochemical evaluation of two
Toxoplasma gondii GRA8 sequences to detect acute toxoplasmosis infection. Microb Pathog 2016;100:229-236.
30. Verma R, Khanna P. Development of
Toxoplasma gondii vaccine: a global challenge. Hum Vaccin Immunother 2013;9:291-293.
32. Chen J, Li ZY, Petersen E, Huang SY, Zhou DH, Zhu XQ. DNA vaccination with genes encoding
Toxoplasma gondii antigens ROP5 and GRA15 induces protective immunity against toxoplasmosis in Kunming mice. Expert Rev Vaccines 2015;14:617-624.
33. Yuan ZG, Zhang XX, Lin RQ, Petersen E, He S, Yu M, He XH, Zhou DH, He Y, Li HX, Liao M, Zhu XQ. Protective effect against toxoplasmosis in mice induced by DNA immunization with gene encoding
Toxoplasma gondii ROP18. Vaccine 2011;29:6614-6619.
34. Zheng L, Hu Y, Hua Q, Luo F, Xie G, Li X, Lin J, Wan Y, Ren S, Pan C, Tan F. Protective immune response in mice induced by a suicidal DNA vaccine encoding NTPase-II gene of
Toxoplasma gondii
. Acta Trop 2017;166:336-342.
35. Wang M, Yang XY, Zhang NZ, Zhang DL, Zhu XQ. Evaluation of protective immune responses induced by recombinant TrxLp and ENO2 proteins against
Toxoplasma gondii infection in BALB/c mice. Biomed Res Int 2016;2016:3571962.
36. Chen K, Wang JL, Huang SY, Yang WB, Zhu WN, Zhu XQ. Immune responses and protection after DNA vaccination against
Toxoplasma gondii calcium-dependent protein kinase 2 (TgCDPK2). Parasite 2017;24:41.
37. Zhang NZ, Xu Y, Wang M, Petersen E, Chen J, Huang SY, Zhu XQ. Protective efficacy of two novel DNA vaccines expressing
Toxoplasma gondii rhomboid 4 and rhomboid 5 proteins against acute and chronic toxoplasmosis in mice. Expert Rev Vaccines 2015;14:1289-1297.
38. Xu Y, Zhang NZ, Tan QD, Chen J, Lu J, Xu QM, Zhu XQ. Evaluation of immuno-efficacy of a novel DNA vaccine encoding
Toxoplasma gondii rhoptry protein 38 (TgROP38) against chronic toxoplasmosis in a murine model. BMC Infect Dis 2014;14:525.
39. Han Y, Zhou A, Lu G, Zhao G, Sha W, Wang L, Guo J, Zhou J, Zhou H, Cong H, He S. DNA vaccines encoding
Toxoplasma gondii cathepsin C 1 induce protection against Toxoplasmosis in mice. Korean J Parasitol 2017;55:505-512.
40. Lee SH, Kim AR, Lee DH, Rubino I, Choi HJ, Quan FS. Protection induced by virus-like particles containing
Toxoplasma gondii microneme protein 8 against highly virulent RH strain of
Toxoplasma gondii infection. PLoS One 2017;12:e0175644.
41. Han Y, Zhou A, Lu G, Zhao G, Wang L, Guo J, Song P, Zhou J, Zhou H, Cong H, He S. Protection via a ROM4 DNA vaccine and peptide against
Toxoplasma gondii in BALB/c mice. BMC Infect Dis 2017;17:59.
42. Liu CH, Fan YT, Dias A, Esper L, Corn RA, Bafica A, Machado FS, Aliberti J. Cutting edge: dendritic cells are essential for in vivo IL-12 production and development of resistance against
Toxoplasma gondii infection in mice. J Immunol 2006;177:31-35.
43. Gazzinelli RT, Wysocka M, Hayashi S, Denkers EY, Hieny S, Caspar P, Trinchieri G, Sher A. Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with
Toxoplasma gondii
. J Immunol 1994;153:2533-2543.
44. Hunter CA, Sibley LD. Modulation of innate immunity by
Toxoplasma gondii virulence effectors. Nat Rev Microbiol 2012;10:766-778.